VIDEO: Alzheimer’s anti-tau drug fails, but shows hint of effect when taken alone
TORONTO – A highly anticipated phase III trial of an anti-tau drug has posted negative topline results, conferring no cognitive or functional benefits when given in conjunction with standard-of-care... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 27, 2016 Category: Neurology Source Type: news
VIDEO: Proposed Alzheimer’s funding boost could mean wider research scope
TORONTO – In 2011, President Barack Obama signed into law the <a... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 26, 2016 Category: Neurology Source Type: news
FDA updates warning label for systemic fluoroquinolones
The Food and Drug Administration has amended the boxed warning on labels for fluoroquinolone antibiotics, taken either orally or by injection, to reflect recent findings of the drugs’ alarming... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 26, 2016 Category: Neurology Source Type: news
Medicare annual wellness visit remains underused
TORONTO – The annual Medicare wellness visit offers patients and their doctors the chance to review a variety of health concerns, and includes a cognitive health checkup. It’s free for patients and... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 26, 2016 Category: Neurology Source Type: news
VIDEO: Medicare pays billions for potentially avoidable hospital admissions in dementia patients
TORONTO – In 2013, Medicare spent $2.6 billion on potentially avoidable hospitalizations for patients with Alzheimer’s disease and other dementias.
About half of these hospital visits – each of... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 26, 2016 Category: Neurology Source Type: news
VIDEO: Loss of function in Rab10 gene cuts Alzheimer’s risk by up to 40%
TORONTO – A rare loss of function in a gene that influences gamma secretase trafficking has been found to reduce the risk of Alzheimer’s by up to 40%, even in people who are homozygous carriers of... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 25, 2016 Category: Neurology Source Type: news
Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
TORONTO – Hallucinations – especially auditory hallucinations – triple the risk that a risperidone-controlled Alzheimer’s patient with psychoses will relapse if the drug is withdrawn.
“I think the... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 25, 2016 Category: Neurology Source Type: news
Hemophilia drugs top Medicaid spending per prescription
Medicaid’s three most expensive drugs by spending per prescription were for treatment of hemophilia, with the cost leader coming in at almost $59,000, according to an analysis by the Kaiser Family... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 23, 2016 Category: Neurology Source Type: news
CMS seeks input on future of Open Payments program
The Centers for Medicare & Medicaid Services is seeking physician input on the Open Payments program.
The agency signaled its intent to gather information in its <a... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 21, 2016 Category: Neurology Source Type: news
Intermediate alleles may confer mild, late-onset Huntington-like symptoms
Asymptomatic people who carry an intermediate number (27-35) of CAG repeats on the huntingtin gene – that is, the range just below the Huntington’s disease threshold of 36 CAG repeats – may be at... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 21, 2016 Category: Neurology Source Type: news
Feds sue to block mega-mergers by health insurers
The U.S. Department of Justice (DOJ) is suing to block two mega-mergers between four of the largest health insurers in the nation, claiming the alignments will harm competition and reduce patient... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 21, 2016 Category: Neurology Source Type: news
Lessons learned from merging EHR systems
WASHINGTON – As practices merge, how hard is it to merge EHRs?
Even in what might seem to be the best circumstances, it can be a huge challenge, according to <a... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 21, 2016 Category: Neurology Source Type: news
Start time for estrogen conveys no cognitive impact
The cognitive effects of estrogen were no different in women who started taking the hormone within 6 years of menopause, compared with those who began it 10 or more years after menopause, based on... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 20, 2016 Category: Neurology Source Type: news
FDA accepting comments on draft guidelines on compounding law
The Food and Drug Administration is currently accepting public comments on the agency’s proposed plans to implement a law that will restrict compounding of human drug products.
A <a... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 20, 2016 Category: Neurology Source Type: news
Buprenorphine implants rival daily sublingual buprenorphine for opioid dependence
Using an implant device to administer buprenorphine for adult patients being treated for opioid addiction is a viable alternative to the standard sublingual buprenorphine, a randomized clinical trial... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 20, 2016 Category: Neurology Source Type: news
